Biotech ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – FBIO January 16, 2021
Biotech ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. – ANCN January 16, 2021
Biotech Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares January 15, 2021
Biotech Cardiff Oncology Presents Data that Continues to Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access Program January 15, 2021
Biotech SHAREHOLDER ALERT: WeissLaw LLP Reminds CGIX, NPA, THBR and GIX Shareholders About Its Ongoing Investigations January 14, 2021
Biotech ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fortress Biotech, Inc. Investors to Seek Counsel Before Important January 26 Deadline in Securities Class Action- FBIO January 14, 2021
Search
Biotech
January 16, 2021
January 16, 2021
January 15, 2021
January 15, 2021
January 15, 2021
January 15, 2021
January 14, 2021
January 14, 2021
January 14, 2021
January 14, 2021
